Integral Procedures in Pharmacokinetics and their Application to the Parameter Determination of Appearing Metabolites

  • Edward R. Garrett

Abstract

The pharmacokinetics of a substance are studied best by the simultaneous measurement of the drug and all of its possible metabolites, especially if they possess similar pharmacological activities, in all monitorable tissues of the animal (1,2). The mathematical delineation of the plasma concentration-time course of the administered drug yields only an equation. Thus, it is difficult to predict the time course of drug and metabolites in plasma and urine under selected conditions of dose and administration. An integrated model, that quantitatively describes the tissue concentrations, interconversions, transformations, and excretory patterns of the drug and its metabolites as functions of the dose, may permit correlations with pharmacodynamic activities and give insight into the mechanisms of action.

Keywords

Hydrolysis HPLC Manifold Catalysis Morphine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    E.R. Garrett and A. Jackson, Pharmacokinetics of morphine and its surrogates III: Morphine and morphine 3-monoglucuronide in the dog as a function of dose, J. Pharm. Sci. 68: 753–771 (1979).PubMedCrossRefGoogle Scholar
  2. 2.
    E.R. Garrett and T. Gtfrkan, Pharmacokinetics of morphine and its surrogates IV: Pharmacokinetics of heroin and its derived metabolites in the dog, J. Pharm. Sci. 69: 1116–1134 (1980).PubMedCrossRefGoogle Scholar
  3. 3.
    M. Rowland, L.Z. Benet and G.G. Graham, Clearance concepts in pharmacokinetics, J. Pharmacokin. Biopharm. 1: 123–136 (1973).CrossRefGoogle Scholar
  4. 4.
    G.R. Wilkinson and D.G. Shand, A physiological approach to hepatic drug clearance, Clin. Pharmacol. Ther. 18: 377–390 (1975).PubMedGoogle Scholar
  5. 5.
    E.R. Garrett, Pharmacokinetics and clearances related to renal processes, Int. J. Clin. Pharmacol. 16: 155–172 (1978).Google Scholar
  6. 6.
    E.R. Garrett, Classical pharmacokinetics to the frontier, J. Pharmacokin. Biopharm. 1: 341–361 (1973).CrossRefGoogle Scholar
  7. 7.
    E.R. Garrett, Theoretische Pharmakokinetik, in “Klinische Pharmacologic and Pharmakotherapie,” (Vol. 3 ), H. Kuemmerle, E.R. Garrett and K.H. Spitzy, eds., Urban and Schwarzenberg, München (1976).Google Scholar
  8. 8.
    E.R. Garrett and H.J. Lambert, Pharmacokinetics of trichloro-ethanol and metabolites and the interconversions among variously referenced pharmacokinetic parameters, J. Pharm. Sci 62: 550–572 (1973).PubMedCrossRefGoogle Scholar
  9. 9.
    E.R. Garrett, J. Bres and K. Schnelle, Pharmacokinetics of saturably metabolized amobarbital, J. Pharmacokin. Biopharm. 2: 43–103 (1974).CrossRefGoogle Scholar
  10. 10.
    L.Z. Benet and R.L. Galeazzi, Noncompartmental determination of the steady-state volume of distribution, J. Pharm. Sci. 68: 1071–1074 (1979).PubMedCrossRefGoogle Scholar
  11. 11.
    E.R. Garrett, Evidence for general base catalysis in an ester hydrolysis II. Hydrolysis of an aminoalkyl acetylsalicylate, J. Amer. Chem. Soc. 80: 4049–4056 (1958).CrossRefGoogle Scholar
  12. 12.
    E.R. Garrett, R.S. Süverkrüp, K. Eberst, R.L. Yost and J.P. O’Leary, Surgically affected sulfisoxazole pharmacokinetics in the morbidly obese, Biopharm. Drug Disp. 2: 329–365 (1981).CrossRefGoogle Scholar
  13. 13.
    Program stat-l-27A Multiple Linear Regression in HP-65, stat Pac 1, Hewlett-Packard Co., Palo Alto, California (1974): Based on A.M. Mood and F.A. Grayhill, “Introduction to the Theory of Statistics”, McGraw-Hill, New York, NY (1963).Google Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Edward R. Garrett
    • 1
  1. 1.The Beehive College of Pharmacy J. Hillis Miller Health CenterUniversity of FloridaGainesvilleUSA

Personalised recommendations